20-F/A: Opthea Files Amendment to 20-F, Citing Audit Firm Signature Omission and New Certifications
20-F/A Filing
Opthea Limited amends its 20-F filing to include the auditor's signature, new certifications, and minor text adjustments.
Summary
- Opthea Limited filed an amendment to its Form 20-F for the fiscal year ended June 30, 2024.
- The amendment addresses the omission of the independent auditor's signature, includes new Section 302 and 906 certifications, and corrects the Exhibit Index.
- The original filing's content remains unchanged, reflecting data as of the original filing date.
- Forward-looking statements have not been updated and should be read in their historical context.
- The company had 1,091,466,771 ordinary shares outstanding as of the close of the period covered by the annual report.
- The company had 11,558,534 American Depositary Shares outstanding as of the close of the period covered by the annual report.
Sentiment
Score: 5
Explanation: The document is neutral in sentiment, primarily addressing compliance and corrections in financial reporting.
Negatives
- The company identified a material weakness in its internal control over financial reporting because it did not design and maintain effective controls in relation to accounting for non-routine transactions and its related note disclosures which resulted in its failure to prevent and detect material errors which were corrected in its consolidated financial statements as of and for the year ended June 30, 2024 related to the (1) remeasurement of the financial liabilities in connection with our Funding Agreement and (2) the accounting application and related disclosures of investor options issued during the year.
Future Outlook
The company expects to continue incurring significant expenses as it advances sozinibercept through clinical development and seeks regulatory approval.
Industry Context
The announcement is specific to Opthea and its financial reporting obligations, with no direct commentary on broader industry trends.
Stakeholder Impact
- The amendment ensures accurate financial reporting, which is important for shareholders and potential investors.
Key Dates
| Date | Description |
|---|---|
| 1934 | Securities Exchange Act of 1934 |
| 2001 | Australian Corporations Act 2001 |
| 2010 | Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 |
| 2022-08-12 | Original Development Funding Agreement with Ocelot SPV LP |
| 2023-08-30 | Original Filing |
| 2023-12-22 | Amended and Restated Development Funding Agreement |
| 2024-06-30 | Fiscal year ended June 30, 2024 |
| 2024-08-30 | Filing date of this Amendment |
| 2025-02-28 | Date |
Keywords
20-F/A, amendment, financial statements, internal control, certifications, Opthea Limited
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.